Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin adjunct to narrative exposure therapy for PTSD
NL-OMON37116Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Oxytocin + NET with Placebo + NET (2 arms). Primary endpoint: PTSD symptom level. Planned start Dec 2012; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON37116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37116.